Adorable, Feliciana D.

HRN: 17-47-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2025
CEFTRIAXONE 1G (VIAL)
04/16/2025
04/30/2025
IV
2g
Q12hrs
Pleural Effusion S/t Parapneumonic Process Vs Ptb
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: